board of directors GA4GH Incorporates as a Not-For-Profit Organization in Canada As a formal not-for-profit, the group is able to raise funds from private entities and enter into formal contracts as it positions itself as an international standards organization. Qlucore Expands Into Diagnostics, Precision Medicine With New Informatics Offering Premium The new Qlucore Diagnostics software builds on the recently updated Qlucore Omics Explorer platform, initially to help clinicians diagnose and treat leukemia. Lone Star Withdraws Effort to Replace Enzo Board Members After ISS Supports Firm's Candidates The investment firm had sought to place two candidates on Enzo's board but withdrew its proxy contest after failing to gain ISS's endorsement. UPDATE: Investment Firm Agitates for Change in Enzo Biochem's Board The Enzo shareholder issued an open letter stating its concern about the company's stock performance. Epic Sciences Raises $30M in Private Financing; Lucier Named Chairman NEW YORK (GenomeWeb) – Epic Sciences has raised $30 million in a Series C round of private financing that it will use to support development of its circulating tumor cell analysis platform. Mar 27, 2013 Dissident Shareholder Goggin Wins Seat on Vermillion's Board of Directors Mar 11, 2013 Proxy Advisory Firm Suggests Vermillion Shareholders Elect Dissident Shareholder to Board Feb 14, 2013 Nanosphere's Revenues Double as Firm Names New CEO; Stock Plummets Nov 28, 2012 Genetic Technologies Names New Chairman, Acting CEO Nov 27, 2012 Genetic Technologies CEO, Others Resign Following Annual Meeting Jul 3, 2012 Pressure BioSciences Aims to Raise $1.2M in Private Placement May 15, 2012 Bruker Disagrees with ISS Recommendation on Board Vote Apr 18, 2012 Roche Won't Extend Offer for Illumina as Shareholders Re-elect Flatley, Others to Board Apr 17, 2012 Analyst: Illumina Shareholders Unlikely to Vote for Roche Offer, but Options Remain Apr 10, 2012 Third Proxy Firm Favors Re-election of Illumina Board Members over Roche Candidates Apr 6, 2012 ISS Recommends Illumina Shareholders Vote Against Roche's Nominees for Board Apr 2, 2012 Illumina Rejects Roche's Latest Offer Mar 20, 2012 Roche Files Proxy, Sends Letter to Illumina Shareholders Mar 19, 2012 Illumina Sets April 18 Date for Shareholder Meeting with Roche Proposal at Stake Feb 29, 2012 Vermillion Shareholders Seek Change in Board Members Jan 31, 2012 Roche Names Proposed Board Nominees for Illumina Nov 23, 2011 Response Biomedical Inks C$2M Debt Financing Pact Sep 15, 2011 Horizon Discovery Raises $18.6M in Series C Round Sep 17, 2010 Response Genetics Settles Proxy Contest; Revises Slate of Board Nominees Apr 5, 2010 Fund Seeks New Board Members for Orchid Cellmark Load More Breaking News Ceres Nanosciences Wins $1.4M in NIH RADx Funding for Additional Wastewater Epidemiology Centers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer GenomeWeb Top 40 up 8 Percent in November, Outpacing Broader Market Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay ERS Genomics Licenses CRISPR-Cas9 IP to Cosmo Bio The Scan New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability. Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances. New mRNA Vaccines Offer Hope for Fighting Malaria A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines. Unique Germline Variants Found Among Black Prostate Cancer Patients Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.